IP Library › Granted Patent US 10,667,729
Granted Patent B2
US 10,667,729 · App. 16/455,468 · Granted Jun 2, 2020

Analyte sensing biointerface

Inventors: Peter C. Simpson (Cardiff, CA); James H. Brauker (Coldwater, MI)
Assignee: DexCom, Inc.
A61B5/14532A61B5/1486A61B5/14865C12Q1/001C12Q1/006A61B5/0031B33Y80/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,667,729
App. No.
16/455,468
Granted
Jun 2, 2020
Kind
B2
Abstract

Disclosed herein is an analyte sensing biointerface that comprises a sensing electrode incorporated within a non-conductive matrix comprising a plurality of passageways extending through the matrix to the sensing electrode. Also disclosed herein are methods of manufacturing a sensing biointerface and methods of detecting an analyte within tissue of a host using an analyte sensing biointerface.

Claims (18)

1. A transcutaneous continuous glucose sensor system, comprising:

a substantially planar sensor, the sensor comprising:

a first non-conductive layer;

a first conductive layer associated with a first electrode, wherein the first conductive layer is disposed at least in part over the first non-conductive layer;

a second non-conductive layer disposed at least in part over the first conductive layer;

a second conductive layer associated with a second electrode, wherein the second conductive layer is disposed at least in part over the second non-conductive layer;

a third non-conductive layer disposed at least in part over the second conductive layer;

a third conductive layer associated with a third electrode, wherein the third conductive layer is disposed at least in part over the third non-conductive layer; and

a membrane disposed over at least a portion of a working electrode;

wherein at least one of the first electrode, the second electrode, or the third electrode is the working electrode, and wherein the working electrode is configured to measure a signal indicative of a glucose concentration.

2. The transcutaneous continuous glucose sensor system of claim 1 , wherein the membrane comprises an enzyme.

3. The transcutaneous continuous glucose sensor system of claim 2 , wherein the membrane further comprises a resistance domain disposed over the enzyme.

4. The transcutaneous continuous glucose sensor system of claim 1 , wherein the membrane comprises a bioactive agent.

5. The transcutaneous continuous glucose sensor system of claim 1 , wherein the membrane is substantially planar.

6. The transcutaneous continuous glucose sensor system of claim 1 , wherein at least a portion of the first non-conductive layer is in physical contact with at least a portion of the first conductive layer.

7. The transcutaneous continuous glucose sensor system of claim 1 , further comprising sensor electronics configured to electrically couple to the working electrode.

8. The transcutaneous continuous glucose sensor system of claim 1 , wherein at least a portion of the first non-conductive layer is physically separate from the first conductive layer.

9. The transcutaneous continuous glucose sensor system of claim 1 , further comprising sensor electronics having one or more contacts for operably connecting to the working electrode.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2020
From: SIMPSON, PETER C.; BRAUKER, JAMES H.
To: DEXCOM, INC.
Reel/Frame 052359/0488 →
Continuity (7)
Continuation 15711225 · Sep 21, 2017
Continuation 14281697 · May 19, 2014
Continuation 13285880 · Oct 31, 2011
Continuation 11404929 · Apr 14, 2006
Provisional Application 60671622 · Apr 15, 2005
Provisional Application 60683923 · May 23, 2005
Related Publication 20190313952A1 · Oct 17, 2019
Cited By (2)
US 12,279,865 US 12,666,543